PROX1 and colorectal carcinoma: In addition, the results strongly indicate that CRC ‘sphere-assays’ enable the measurement of self-renewing capacity of a distinct PROX1+ CSC subtype and that more differentiated subtypes have limited potential to self-renew in-vitro1.